Xvivo Perfusion AB (FRA:3XV) FCF Margin % : 0.86% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Xvivo Perfusion AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Xvivo Perfusion AB's Free Cash Flow for the three months ended in Mar. 2024 was €0.14 Mil. Xvivo Perfusion AB's Revenue for the three months ended in Mar. 2024 was €16.44 Mil. Therefore, Xvivo Perfusion AB's FCF Margin % for the quarter that ended in Mar. 2024 was 0.86%.

As of today, Xvivo Perfusion AB's current FCF Yield % is 0.52%.

The historical rank and industry rank for Xvivo Perfusion AB's FCF Margin % or its related term are showing as below:

FRA:3XV' s FCF Margin % Range Over the Past 10 Years
Min: -42.78 Med: -19.81 Max: 9.31
Current: 9.31

During the past 12 years, the highest FCF Margin % of Xvivo Perfusion AB was 9.31%. The lowest was -42.78%. And the median was -19.81%.

FRA:3XV's FCF Margin % is ranked better than
78.76% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: -7.14 vs FRA:3XV: 9.31

Xvivo Perfusion AB FCF Margin % Historical Data

The historical data trend for Xvivo Perfusion AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB FCF Margin % Chart

Xvivo Perfusion AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-24.54

-42.78

-41.07

-24.82

-16.34

Xvivo Perfusion AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-8.84	10.19	16.95	11.64	0.86

Competitive Comparison of Xvivo Perfusion AB's FCF Margin %

For the Medical Devices subindustry, Xvivo Perfusion AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xvivo Perfusion AB's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Xvivo Perfusion AB's FCF Margin % falls into.

Xvivo Perfusion AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Xvivo Perfusion AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-8.729	/	53.419
	=	-16.34 %

Xvivo Perfusion AB's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0.141	/	16.438
	=	0.86 %

Xvivo Perfusion AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Xvivo Perfusion AB (FRA:3XV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (FRA:3XV) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

XVIPF:USA XVIVO:Sweden

Address

Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14

Website

https://www.xvivoperfusion.com

Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (FRA:3XV) Headlines

No Headlines